Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease
NCT06527846 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1024
Last updated 2026-03-19
Summary
Study objective is to investigate the safety and effectiveness of long-term daily use of JARDIANCE® Tablets in patients with chronic kidney disease under real-world use.
Conditions
- Kidney Disease, Chronic
Interventions
- DRUG
-
JARDIANCE®
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-22
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
Countries
- Japan
Study Locations
More Related Trials
-
A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease
NCT06610526 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study
NCT02316821 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
NCT04990427 ·Status: COMPLETED ·Phase: PHASE1
-
OPTIMISE-CKD Drug Utilization
NCT05932901 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
NCT05687890 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01500798 ·Status: TERMINATED ·Phase: PHASE1
-
Bioequivalence Study of Empagliflozin 25 mg Film-coated Tablets in Healthy Thai Volunteers
NCT06337409 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated
NCT03550378 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
NCT02065791 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants
NCT06651021 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)
NCT05769595 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
NCT05373004 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
NCT02312050 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy
NCT03436693 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension
NCT06933355 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes
NCT06415214 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease
NCT04750577 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01551446 ·Status: WITHDRAWN ·Phase: PHASE1
-
This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)
NCT03165227 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan
NCT03627715 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
NCT01683409 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01574365 ·Status: TERMINATED ·Phase: PHASE2
-
An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
NCT01064414 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
NCT01621178 ·Status: COMPLETED ·Phase: PHASE3